XGN
Exagen Inc.
NASDAQHealthcareMedical - Diagnostics & ResearchUS
Rating:C-
Company Profile
CEO
John Aballi
IPO Date
2019-09-19
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Exagen Inc.
CEO
John Aballi
IPO Date
2019-09-19
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
| $0.00 |
| 16 Mar 2026 | Black Jeffrey G. | Chief Financial Officer | A-Award | Acquired | 75,000 | $3.16 |
| 16 Mar 2026 | Black Jeffrey G. | Chief Financial Officer | A-Award | Acquired | 1,511 | $3.08 |
| 16 Mar 2026 | Black Jeffrey G. | Chief Financial Officer | A-Award | Acquired | 50,000 | $3.16 |
| 16 Mar 2026 | ABALLI JOHN | director, officer: President and CEO | A-Award | Acquired | 150,000 | $0.00 |
| 16 Mar 2026 | ABALLI JOHN | director, officer: President and CEO | A-Award | Acquired | 100,000 | $3.16 |
| 4 Mar 2026 | ABALLI JOHN | director, officer: President and CEO | S-Sale | Disposed | 15,698 | $3.62 |
| 4 Mar 2026 | ABALLI JOHN | director, officer: President and CEO | A-Award | Acquired | 2,535 | $3.08 |
| 25 Feb 2026 | ABALLI JOHN | director, officer: President and CEO | S-Sale | Disposed | 11,430 | $3.61 |